title: Facial vasculitic rash associated with intravenous immunoglobulin.
authors.affiliation: South Tees Acute Hospitals Trust, Middlesbrough TS4 3BW.
authors.forename: M
authors.initials: M
authors.lastname: Howse
authors.forename: L
authors.initials: L
authors.lastname: Bindoff
authors.forename: A
authors.initials: A
authors.lastname: Carmichael
mesh_terms: D000287:Administration, Topical; D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017332:Cetirizine / Q000627:therapeutic use; D002990:Clobetasol / Q000031:analogs & derivatives / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005148:Facial Dermatoses / Q000139:chemically induced*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000209:etiology*
chemical_list: D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; C010893:clobetasone butyrate; D002990:Clobetasol; D017332:Cetirizine